Javier San - Apr 15, 2024 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Mark Worthington, Attorney-in-Fact for Javier San Martin
Stock symbol: ATHA
Transactions as of: Apr 15, 2024
Transactions value $: $0
Form type: 4
Date filed: 4/16/2024, 04:37 PM
Previous filing: Jan 8, 2024
Next filing: Oct 3, 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATHA	Stock Option (Right to Buy)	Award	$0	+400K		$0.00	400K	Apr 15, 2024	Common Stock	400K	$2.06	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Twenty-five percent (25%) of the shares subject to the option will vest on the one (1) year anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2024 Inducement Equity Incentive Plan) through the applicable vesting dates.